Exciting news for the life science industry as Element Biosciences, a groundbreaking company revolutionizing access to advanced biological tools, has successfully raised an impressive $277,000,000 in funding. Element Biosciences is on a mission to democratize cutting-edge DNA sequencing and multiomics technology for research markets, ultimately driving impactful discoveries to benefit humanity. By innovating every aspect of biological assay systems, Element aims to provide customers with affordable, high-quality data and an enhanced user experience that will significantly speed up scientific breakthroughs. This substantial funding round will enable Element Biosciences to further develop its disruptive technologies and expand its reach within the industry, paving the way for even more significant advancements in the field of life sciences.
Breaking Barriers in Life Science: Element Biosciences Secures $277M in Funding for Advanced DNA Sequencing Technology
Recently funded 路 $277.0MBiotechnology
Get the full Element Biosciences company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Lane
Lane is the world鈥檚 leading workplace experience platform. Founded in 2014 to transform and connect the workplace, our no-code enterprise software streamlines all aspects of day-to-day office life鈥攆rom room bookings and access management, to communications and commerce, to events, data, and beyond. Our award-winning mobile and web technology is built to scale, allowing workplace providers to deploy globally and configure locally. Powering 300+ properties across 22 major cities in 8 countries, Lane clients include Brookfield, Oxford, Colliers, Dream, Nuveen, Studio by Tishman Speyer, and more. Putting all of the pieces together, Lane turns any workplace into a place that works. www.joinlane.com www.twitter.com/joinlane www.instagram.com/join_lane
$1.0M Pre-seed
today
Clarity Systems
AI for Retail Returns
$4.4M Seed
today
